Helicobacter pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: Two-drug regimen including amoxicillin 1 gram twice daily and venoprazan 20 mg twice daily for 14 days. All drugs are products of Abidi Company. Intervention 2: Int
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age 18 to 70 years Definite diagnosis of Helicobacter pylori infection Willingness and ability to participate in the study and complete the treatment course
Exclusion criteria
Exclusion criteria: History of previous treatment for Helicobacter pylori eradication Taking antibiotics or proton pump inhibitors within the past four weeks Known allergy to any of the drugs used in the study Having significant underlying diseases or comorbidities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication. Timepoint: 8 weeks after the start of the intervention. Method of measurement: Stool antigen test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: During the 14-day treatment period. Method of measurement: Clinical history. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahbod Sianpanah
Shahid Beheshti University of Medical Sciences
Outcome results
None listed